Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Icodextrin for Small Bowel Obstruction Prevention in Colorectal Cancer
NCT02318888Unknown
- Sponsor
- Uppsala University
- Start
- Dec 2009
- Primary completion
- Dec 2022
- Modality
- Polymer-based Nanoparticles, Device-based Delivery
- Countries
- 1
01
Overview
Randomised, open-label trial of icodextrin in adhesion (post-surgical) and small bowel obstruction (SBO), sponsored by Uppsala University. Primary endpoint: Surgery for small bowel obstruction at 5 years. Status: unknown.
02
Drugs
icodextrin
03
Conditions
adhesion (post-surgical)small bowel obstruction (SBO)
Beyond the preview
Go deeper on NCT02318888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02318888.